Development Level

Tclin 3 | 602
Tbio 2 | 10,625
Tchem 2 | 1,890

IMPC Term

abnormal bone structure 1 | 131
decreased bone mineral content 1 | 157
decreased circulating alkaline... 1 | 41
improved glucose tolerance 1 | 56
increased circulating serum al... 1 | 25

Disease

Alzheimer's disease 6 | 644
Cancer 6 | 2,346
Hypertension 6 | 287
Parkinson's disease 6 | 364
Schizophrenia 6 | 501
diabetes mellitus 6 | 1,663
psoriasis 6 | 6,685
Allergic hypersensitivity disease 5 | 123
Asthma 5 | 349
Dementia 5 | 129
Dermatitis 5 | 107
Diarrhea 5 | 155
Inflammatory bowel disease 5 | 142
Irritable bowel syndrome 5 | 59
Major Depressive Disorder 5 | 106
Neuropathy 5 | 210
Obesity 5 | 616
Pain agnosia 5 | 99
Pancreatitis 5 | 97
interstitial cystitis 5 | 2,299
Arthritis 4 | 248
Arthritis, Experimental 4 | 39
Bipolar Disorder 4 | 266
Bronchitis 4 | 44
Cerebrovascular disease 4 | 231
Cystitis 4 | 16
Endometriosis 4 | 535
Gastritis 4 | 44
Hyperalgesia 4 | 71
Hyperglycemia 4 | 120
Hypersensitivity 4 | 63
Hypotension 4 | 53
Inflammation 4 | 109
Kidney disease 4 | 396
Urticaria 4 | 53
cystic fibrosis 4 | 1,665
lung cancer 4 | 4,466
pilocytic astrocytoma 4 | 3,086
sarcoidosis 4 | 358
tuberculosis 4 | 1,557
ulcerative colitis 4 | 2,087
Acquired immunodeficiency syndrome 3 | 164
Amyloidosis 3 | 68
Anemia 3 | 252
Aortic aneurysm 3 | 34
Atherosclerosis 3 | 275
Brain Ischemia 3 | 87
Brain disease 3 | 83
Candidiasis 3 | 48
Cardiomyopathies 3 | 90
Cerebrovascular accident 3 | 44
Colitis 3 | 46
Collagen disease 3 | 25
Common cold 3 | 63
Coronary artery disease 3 | 240
Dermatologic disorders 3 | 65
Diabetes Mellitus, Experimental 3 | 106
Diabetic Retinopathy 3 | 53
Drug-Induced Liver Injury 3 | 118
Edema 3 | 38
Exanthem 3 | 39
Fatty liver disease 3 | 84
Glomerulonephritis 3 | 36
Gout 3 | 93
Heart disease 3 | 279
Heart failure 3 | 80
Hepatitis C 3 | 90
Huntington's disease 3 | 72
Hyperinsulinism 3 | 63
Hypoglycemia 3 | 81
Infertility 3 | 163
Influenza 3 | 142
Leishmaniasis 3 | 49
Leukopenia 3 | 42
Liver disease 3 | 219
Lung Neoplasms 3 | 171
Lung disease 3 | 132
Malaria 3 | 140
Mammary Neoplasms 3 | 410
Mastitis 3 | 48
Meningitis 3 | 46
Metabolic syndrome X 3 | 155
Multiple Sclerosis 3 | 498
Myocardial Infarction 3 | 126
Myopathy 3 | 128
Narcolepsy 3 | 58
Necrosis 3 | 51
Osteoporosis 3 | 257
Otitis media 3 | 32
Peritonitis 3 | 37
Pneumonia 3 | 133
Pulmonary Fibrosis 3 | 66
Reperfusion Injury 3 | 84
Rhinitis 3 | 46
Seizures 3 | 95
Stomach Neoplasms 3 | 282
Thyroid Neoplasm 3 | 33
Toxic encephalopathy 3 | 131
Toxic shock syndrome 3 | 28
Vasculitis 3 | 64

Tissue

Endocrine System 7 | 18,512
Female tissues 7 | 18,647
Nervous System 7 | 18,561
Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 7 | 11,971

Grant Application

5R01NS042604-04 7 | 7
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-1 beta IL1B Tclin Non-IDG -4.34333 22444.2 1345
Somatostatin SST Tchem Non-IDG -4.13259 13272.3 348
Tumor necrosis factor TNF Tclin Non-IDG -4.68994 50044.6 2261
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Protachykinin-1 TAC1 Tbio Non-IDG -4.12709 13651.7 395
Interleukin-6 IL6 Tclin Non-IDG -4.44733 28484.7 1664